The vision of AFT Orphan is to be the leading company in Southeast Asia providing access to orphan medicines for patients suffering from rare diseases.
More specifically, we:
- provide a low-risk and cost-effective solution for biotech companies with commercialised orphan drugs to access our markets of expertise
- leverage established infrastructure and widespread industry expertise to ensure rapid patient and physician access to important life changing therapies
- build custom solutions for the ethical medical promotion of orphan drugs (which can include central teams operating regionally and/or individual country sales)
We provide reassurance to partners that our promotion of orphan treatments will be ethical and backed by ‘best-in-class’ operations, supply chain and pharmaco-vigilance.
Our Competitive Advantage
The AFT Orphan competitive advantage is that we can leverage a unique depth of functional experience within the team.
With fully established capabilities in research and development, clinical trial database management (patient registries), regulatory, supply chain and pharmaco-vigilance, we provide the ideal base to build a bespoke medical/marketing organisation to maximise orphan success across the region.
To discuss further, please contact us.